ATE347359T1 - Verwendung von dexmedetomidine zur sedierung auf der intensivstation - Google Patents

Verwendung von dexmedetomidine zur sedierung auf der intensivstation

Info

Publication number
ATE347359T1
ATE347359T1 AT99913332T AT99913332T ATE347359T1 AT E347359 T1 ATE347359 T1 AT E347359T1 AT 99913332 T AT99913332 T AT 99913332T AT 99913332 T AT99913332 T AT 99913332T AT E347359 T1 ATE347359 T1 AT E347359T1
Authority
AT
Austria
Prior art keywords
dexmedetomidine
icu
sedation
Prior art date
Application number
AT99913332T
Other languages
English (en)
Inventor
Riku Aantaa
Romeo Bachand
Esa Heinonen
Original Assignee
Orion Corp
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE347359(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp, Hospira Inc filed Critical Orion Corp
Application granted granted Critical
Publication of ATE347359T1 publication Critical patent/ATE347359T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99913332T 1998-04-01 1999-03-31 Verwendung von dexmedetomidine zur sedierung auf der intensivstation ATE347359T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04

Publications (1)

Publication Number Publication Date
ATE347359T1 true ATE347359T1 (de) 2006-12-15

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913332T ATE347359T1 (de) 1998-04-01 1999-03-31 Verwendung von dexmedetomidine zur sedierung auf der intensivstation

Country Status (27)

Country Link
EP (1) EP1069893B1 (de)
JP (1) JP4606581B2 (de)
KR (1) KR20010034728A (de)
CN (1) CN1168441C (de)
AR (1) AR015744A1 (de)
AT (1) ATE347359T1 (de)
AU (1) AU754484B2 (de)
BG (1) BG64540B1 (de)
BR (1) BR9909872A (de)
CA (1) CA2326339C (de)
CZ (1) CZ301013B6 (de)
DE (1) DE69934305T2 (de)
DK (1) DK1069893T3 (de)
EA (1) EA005524B1 (de)
ES (1) ES2278441T3 (de)
GB (1) GB2352972B (de)
HU (1) HU229162B1 (de)
IL (1) IL138416A (de)
NO (1) NO329194B1 (de)
NZ (1) NZ507203A (de)
PL (1) PL192517B1 (de)
PT (1) PT1069893E (de)
SI (1) SI1069893T1 (de)
SK (1) SK286160B6 (de)
TR (1) TR200002837T2 (de)
TW (1) TW552136B (de)
WO (1) WO1999049854A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1223931B1 (de) 1999-10-29 2005-12-14 Orion Corporation Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock
KR20070087004A (ko) * 2002-04-08 2007-08-27 엠쥐아이 쥐피, 아이엔씨. 프로포폴의 수용성 프로드럭을 함유하는 약제학적 조성물및 그것을 투여하는 방법
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
ES2573253T3 (es) 2006-09-20 2016-06-06 The Board Of Regents Of The University Of Texas System Métodos para el suministro de anestésicos volátiles para anestesia regional y/o alivio del dolor
CN107661293A (zh) 2008-01-22 2018-02-06 得克萨斯大学体系董事会 用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物
NZ596976A (en) * 2009-05-15 2014-05-30 Recro Pharma Inc Sublingual dexmedetomidine compositions and methods of use thereof
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
JP6268100B2 (ja) 2011-12-11 2018-01-24 レクロ・ファーマ，インコーポレーテッド 鼻腔内デクスメデトミジン組成物およびその使用方法
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
CN104797252B (zh) * 2012-10-15 2016-09-21 奥赖恩公司 减轻噪音厌恶的兽医方法
KR101831536B1 (ko) 2013-07-24 2018-04-04 아이-테크 에이비 표면의 해양 바이오파울링 억제제로서 거울상 이성질체 레보메데토미딘의 용도
KR20180095732A (ko) 2013-10-07 2018-08-27 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
CA2924231C (en) 2013-10-07 2018-04-03 Teikoku Pharma Usa, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
CN106456561B (zh) * 2013-10-07 2020-02-28 帝国制药美国公司 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法
CN115197148B (zh) * 2021-04-02 2023-12-12 四川大学华西医院 一种5-苄基咪唑类化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
CA2326339A1 (en) 1999-10-07
EP1069893A2 (de) 2001-01-24
EA005524B1 (ru) 2005-04-28
ES2278441T3 (es) 2007-08-01
JP2002509880A (ja) 2002-04-02
BG64540B1 (bg) 2005-07-29
TW552136B (en) 2003-09-11
CN1295473A (zh) 2001-05-16
CZ20003484A3 (cs) 2002-01-16
BR9909872A (pt) 2007-11-20
WO1999049854A2 (en) 1999-10-07
CN1168441C (zh) 2004-09-29
AR015744A1 (es) 2001-05-16
HUP0101498A3 (en) 2002-06-28
TR200002837T2 (tr) 2001-01-22
BG104797A (en) 2001-07-31
HU229162B1 (hu) 2013-09-30
IL138416A0 (en) 2001-10-31
JP4606581B2 (ja) 2011-01-05
GB2352972A (en) 2001-02-14
HUP0101498A1 (hu) 2002-03-28
PL192517B1 (pl) 2006-10-31
AU3149499A (en) 1999-10-18
CZ301013B6 (cs) 2009-10-14
PT1069893E (pt) 2007-01-31
NZ507203A (en) 2003-03-28
KR20010034728A (ko) 2001-04-25
CA2326339C (en) 2008-12-23
NO20004931L (no) 2000-09-29
DK1069893T3 (da) 2007-03-19
NO20004931D0 (no) 2000-09-29
EA200001010A1 (ru) 2001-02-26
NO329194B1 (no) 2010-09-13
GB2352972B (en) 2003-05-21
EP1069893B1 (de) 2006-12-06
AU754484B2 (en) 2002-11-14
IL138416A (en) 2005-07-25
SK14362000A3 (sk) 2002-03-05
GB0024932D0 (en) 2000-11-29
SI1069893T1 (sl) 2007-04-30
DE69934305T2 (de) 2007-07-12
PL343553A1 (en) 2001-08-27
DE69934305D1 (de) 2007-01-18
SK286160B6 (sk) 2008-04-07
WO1999049854A3 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
ATE347359T1 (de) Verwendung von dexmedetomidine zur sedierung auf der intensivstation
ATE288424T1 (de) Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
DE60000958D1 (de) Epoxidharzzusammensetzung und ihre Verwendung
DE69903655D1 (de) Verwendung von menthyl-2-pyrrolidon-5-carboxylat zur insektenabwehr
DE60027479D1 (de) Harzstruktur und ihre verwendung
DE60204533D1 (de) Verwendung von Inkjetfarben mit verminderter Korrosion
DE69739892D1 (de) Verwendung von perlförmigen Nahrungsmittelzusätzen
DE59905858D1 (de) Verwendung von pit-emulsionen
DE60121609D1 (de) Modifiziertes polyolefinharz, modifizierte polyolefinharzzusammensetzung und ihre verwendung
ATE251892T1 (de) Schäumende öl-zusammensetzung und ihre verwendung
DE50212455D1 (de) Verwendung von Dimerdiolen
DE60300191T8 (de) Kommunikationsterminal zur Beschränken der Verwendung von Inhalten
DE50106899D1 (de) Y-heckverstrebung zur erhöhung der biege- und torsionssteifigkeit von rohkarosserien
DE69719137D1 (de) Verwendung von oberflächenaktiven Additiven bei der direkten Herstellung von Trialkoxysilane
DE60021903D1 (de) Verwendung von zusammensetzungen zur textilpflege
DE60034106D1 (de) Wässrige emulsionspolymerisat-zusammensetzungen und ihre verwendung zur papierleimung
DE69620914D1 (de) Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung
DE69806419D1 (de) Harzzusammensetzung und ihre Verwendung
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
DE69915486D1 (de) Verwendung von eletriptan zur vorbeugung des wiederauftretens der migräne
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
DE60030366D1 (de) Flexible Harzzusammensetzung und ihre Verwendung
DE69914107D1 (de) Sensor zur auswertung der dielektrischen eigenschaften von spezialpapier
DE50311406D1 (de) Verwendung von Formkörpern
DE60101245D1 (de) Beschichtungszusammensetzung und ihre Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1069893

Country of ref document: EP